Ocular Therapeutix Inc

NASDAQ:OCUL   11:34:10 AM EDT
10.97
+0.46 (+4.38%)
Earnings Announcements

Ocular Therapeutix Announces Second Quarter 2021 Preliminary Net Product Revenue Of $11.7 Million

Published: 07/22/2021 20:52 GMT
Ocular Therapeutix Inc (OCUL) - Ocular Therapeutix™ Announces Second Quarter 2021 Preliminary Net Product Revenue of $11.7 Million.
Ocular Therapeutix Inc - Announces Q2 2021 Preliminary Net Product Revenue of $11.7 Million.
Revenue is expected to be $11.6 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $14.05 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.